Enroll in MIT xPro Course through March 3rd!

Enroll in MIT xPro Course through March 3rd!

Our Principles of Biomanufacturing: Using Biotechnology to Manufacture Medicines online course has just launched. This six-week self-paced course offers scientists, chemists, researchers, program managers, and other biological medicine specialists an opportunity to build an integrated understanding of their role in biomanufacturing. ENROLL NOW!

BioPharm International publishes CBI Article on the Impact of SARS-CoV-2 on Biomanufacturing Operations

BioPharm International publishes CBI Article on the Impact of SARS-CoV-2 on Biomanufacturing Operations

CBI has published a summary of the key takeaways from “The Impact of SARS-CoV-2 on Biomanufacturing Operations”, the first webinar in our ‘Biotechnology in the Age of COVID-19” series co-hosted by CAACB and BioMAN. The summary presents a snapshot of information drawn from expert presentations and a pre-workshop survey of consortia members, covering topics such as…

NEWDIGS offers comment on CMS Proposed Rule supporting Value-Based Purchasing, July 20th, 2020

NEWDIGS offers comment on CMS Proposed Rule supporting Value-Based Purchasing, July 20th, 2020

On behalf of the NEWDIGS initiative / FoCUS Project, team members submitted comments on the recent CMS Proposed Rule supporting Value-Based Purchasing (VBP) (CMS-2482-P). With active input from an engaged set of our cross-sectoral members, we focused on the Proposed Rule as an important step forward in enabling outcomes-based contracting by addressing several Medicaid Best Price methodology challenges.…

BioACCESS Receives Funding to Contribute to IBM Watson’s Initiative: Marshalling AI in the Fight Against COVID-19

BioACCESS Receives Funding to Contribute to IBM Watson’s Initiative: Marshalling AI in the Fight Against COVID-19

The MIT-IBM Watson AI Lab is funding 10 research projects aimed at addressing the health and economic consequences of the pandemic, including BioACCESS’ Overcoming manufacturing and supply hurdles to provide global access to a coronavirus vaccine.  The project, led by CBI’s Anthony Sinskey and Stacy Springs, will build data-driven statistical models to evaluate tradeoffs in scaling the manufacture…